ES2372499T3 - Uso de un detergente para la eliminación no quirúrgica de grasa. - Google Patents

Uso de un detergente para la eliminación no quirúrgica de grasa. Download PDF

Info

Publication number
ES2372499T3
ES2372499T3 ES05722895T ES05722895T ES2372499T3 ES 2372499 T3 ES2372499 T3 ES 2372499T3 ES 05722895 T ES05722895 T ES 05722895T ES 05722895 T ES05722895 T ES 05722895T ES 2372499 T3 ES2372499 T3 ES 2372499T3
Authority
ES
Spain
Prior art keywords
fat
composition
phosphatidylcholine
sodium deoxycholate
detergent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05722895T
Other languages
English (en)
Spanish (es)
Inventor
Michael S. Kolodney
Adam M. Rotunda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Original Assignee
Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34961536&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2372499(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center, University of California Berkeley, University of California San Diego UCSD filed Critical Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center
Application granted granted Critical
Publication of ES2372499T3 publication Critical patent/ES2372499T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Edible Oils And Fats (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
ES05722895T 2004-05-19 2005-02-08 Uso de un detergente para la eliminación no quirúrgica de grasa. Expired - Lifetime ES2372499T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57287904P 2004-05-19 2004-05-19
US572879P 2004-05-19

Publications (1)

Publication Number Publication Date
ES2372499T3 true ES2372499T3 (es) 2012-01-20

Family

ID=34961536

Family Applications (5)

Application Number Title Priority Date Filing Date
ES05722895T Expired - Lifetime ES2372499T3 (es) 2004-05-19 2005-02-08 Uso de un detergente para la eliminación no quirúrgica de grasa.
ES11166225.0T Expired - Lifetime ES2660172T3 (es) 2004-05-19 2005-02-08 Composición inyectable que comprende desoxicolato de sodio
ES05751896T Expired - Lifetime ES2372416T3 (es) 2004-05-19 2005-05-19 Métodos y composiciones relacionadas para la reducción de grasa.
ES20166727T Expired - Lifetime ES2939383T3 (es) 2004-05-19 2005-05-19 Desoxicolato para la reducción de grasa
ES11166230T Expired - Lifetime ES2795749T3 (es) 2004-05-19 2005-05-19 Uso de desoxicolato de sodio para la eliminación no quirúrgica de grasa

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES11166225.0T Expired - Lifetime ES2660172T3 (es) 2004-05-19 2005-02-08 Composición inyectable que comprende desoxicolato de sodio
ES05751896T Expired - Lifetime ES2372416T3 (es) 2004-05-19 2005-05-19 Métodos y composiciones relacionadas para la reducción de grasa.
ES20166727T Expired - Lifetime ES2939383T3 (es) 2004-05-19 2005-05-19 Desoxicolato para la reducción de grasa
ES11166230T Expired - Lifetime ES2795749T3 (es) 2004-05-19 2005-05-19 Uso de desoxicolato de sodio para la eliminación no quirúrgica de grasa

Country Status (25)

Country Link
US (3) US7622130B2 (h)
EP (8) EP2422789B1 (h)
JP (2) JP5060295B2 (h)
KR (1) KR101217497B1 (h)
CN (2) CN105233287A (h)
AT (2) ATE521355T1 (h)
AU (1) AU2005245002B8 (h)
BE (1) BE2017C063I2 (h)
CA (1) CA2567298C (h)
CY (4) CY1111974T1 (h)
DK (5) DK2422789T3 (h)
ES (5) ES2372499T3 (h)
FI (1) FI3692995T3 (h)
FR (2) FR20C1048I2 (h)
HU (5) HUE038247T2 (h)
IL (2) IL179008A (h)
LT (3) LT2422789T (h)
MX (1) MXPA06013437A (h)
NL (1) NL301229I2 (h)
NZ (2) NZ551000A (h)
PL (4) PL1758590T3 (h)
PT (5) PT1758590E (h)
SI (4) SI1758590T1 (h)
TR (1) TR201802446T4 (h)
WO (2) WO2005117900A1 (h)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
PL1758590T3 (pl) * 2004-05-19 2012-03-30 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Zastosowanie detergentu do niechirurgicznego usuwania tłuszczu
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
JP4646669B2 (ja) * 2005-03-30 2011-03-09 キヤノン株式会社 吐出用液体、吐出方法、液滴化方法、カートリッジ及び吐出装置
US20060222695A1 (en) * 2005-04-01 2006-10-05 Filiberto Zadini Deoxycholic acid liposome-based dermatological topical preparation
US20070071706A1 (en) * 2005-09-28 2007-03-29 Filiberto Zadini Lipodissolving dermatological topical preparation
US8304383B2 (en) * 2005-11-22 2012-11-06 Atheronova Operations, Inc. Dissolution of arterial plaque
US20090035348A1 (en) * 2005-11-22 2009-02-05 Z & Z Medical Holdings, Inc. Dissolution of arterial plaque
US7676604B2 (en) * 2005-11-22 2010-03-09 Intel Corporation Task context direct indexing in a protocol engine
US20110082124A1 (en) * 2006-02-23 2011-04-07 Kythera Biopharmaceuticals, Inc. Detergent compositions for treatment of lipomas and other conditions
WO2008008468A2 (en) * 2006-07-14 2008-01-17 Duncan Diane I Compositions and methods for fat reduction
US20100063006A1 (en) * 2006-11-22 2010-03-11 American Network Of Lipolysis, Llc Compositions and methods to reduce fat and retract skin
DE102007015701A1 (de) * 2007-03-19 2008-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung
US8057381B2 (en) * 2007-04-16 2011-11-15 Allen Iii William F Method and implant material for treatment of urinary incontinence
JOP20180077A1 (ar) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
EP2407475B1 (en) * 2007-06-19 2015-08-12 Kythera Biopharmaceuticals, Inc. synthetic bile acid preparation
US7943187B2 (en) 2008-05-23 2011-05-17 Bakr Rabie Paeoniflorin preparations and uses thereof for fat reduction
FR2937554B1 (fr) * 2008-10-27 2010-11-12 Yves Crassas Solutions salines aqueuses pour la destruction de tissus graisseux
EP2403502A4 (en) * 2009-03-02 2012-11-07 Doris Hexsel MEDICAL-COSMETIC LIPOATROPHY
US10213441B2 (en) 2009-03-02 2019-02-26 Doris Hexsel Medicinal cosmetic lipoatrophy
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2485738A4 (en) * 2009-10-09 2015-04-01 Atheronova Operations Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF ADIPOSITAS
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
AU2010359050B2 (en) 2010-08-12 2016-03-17 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
MX363465B (es) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Tratamiento de la grasa submental.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
ES2746311T3 (es) 2011-06-16 2020-03-05 Allergan Sales Llc Composiciones que contienen ácido desoxicólico y agua desionizada al 10 % en etanol, dirigidas a la purificación del ácido desoxicólico
MY184277A (en) * 2011-08-23 2021-03-30 Kythera Biopharmaceuticals Inc Formulations of deoxyccholic acid and salts thereof
RS53419B (en) 2011-08-23 2014-12-31 Kythera Biopharmaceuticals, Inc. FORMULATIONS OF DEOXYCHOLINIC ACID AND ITS SALTS
EA034320B1 (ru) * 2011-08-23 2020-01-28 Китера Биофармасьютикалз, Инк. Композиции дезоксихолата натрия
HUE044650T2 (hu) * 2011-10-21 2019-11-28 Endo Global Ventures Eljárás EFP kezelésére vagy csökkentésére
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
WO2013093947A1 (en) 2011-12-21 2013-06-27 Motolese Pasquale Cosmetic composition and uses thereof in the treatment of lipodystrophies
HUE046160T2 (hu) 2012-01-12 2020-02-28 Endo Global Ventures Clostridium histolyticum enzim
JP5877620B2 (ja) 2012-11-21 2016-03-08 トポカイン セラピューティックス， インコーポレイテッド 体脂肪を局所的に増大させるための方法および組成物
NO2753788T3 (h) 2013-05-10 2018-06-16
WO2014186504A1 (en) 2013-05-15 2014-11-20 Topokine Therapeutics, Inc. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
WO2015179282A1 (en) 2014-05-20 2015-11-26 Topokine Therapeutics, Inc. Topical compositions comprising a thiazolidinedione
EP3148549A4 (en) * 2014-06-01 2017-11-15 Galmed Research and Development Ltd. Fatty acid bile acid conjugates for treatment of lipodystrophy
US10729700B2 (en) * 2014-06-27 2020-08-04 Medytox Inc. Methods and compositions of bile acids and salts for reduction of fat
WO2015200425A1 (en) 2014-06-27 2015-12-30 Topokine Therapeutics, Inc. Topical dosage regimen
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
CA2972065A1 (en) 2014-12-23 2016-06-30 Intellectual Property Associates, Llc Methods and formulations for transdermal administration
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
WO2017059389A1 (en) * 2015-10-01 2017-04-06 Kythera Biopharmaceuticals, Inc. Compositions comprising a statin for use in methods of adipolysis
US20170119794A1 (en) * 2015-11-04 2017-05-04 Kythera Biopharmaceuticals, Inc. Treatments of accumulated fat with deoxycholic acid and salts thereof
JP6219430B2 (ja) * 2016-03-18 2017-10-25 キテラ バイオファーマシューティカルズ，インコーポレイテッド デオキシコール酸およびその塩類の製剤
JP7050008B2 (ja) 2016-06-06 2022-04-07 クリスタル ファーマ，エセ．ア．ウ． デオキシコール酸の調製方法、およびデオキシコール酸の調製に有用な中間体
KR101841193B1 (ko) * 2016-09-22 2018-03-22 이경락 저장성 지방 분해 조성물 및 그의 제조 방법
US20180078621A1 (en) * 2016-09-22 2018-03-22 Kyoung Lack Lee Composition for hypotonic lipolysis and manufacturing method thereof
CN110545722B (zh) 2017-03-01 2023-02-03 恩多风投有限公司 用于评估和治疗橘皮组织的装置和方法
AU2018244426B2 (en) 2017-03-28 2024-09-19 Endo Ventures Limited Improved method of producing collagenase
CA3031678C (en) 2017-04-21 2021-08-31 Ki Taek Lee Injectable composition for localized fat reduction without pain, edema, and side effects, and method for preparing same
KR102093872B1 (ko) * 2017-07-03 2020-03-27 진호성 지방제거용 주사제 조성물 및 이의 제조방법
KR102388809B1 (ko) * 2017-08-03 2022-04-21 (주)메디톡스 담즙산류를 제조하기 위한 방법
JP6356329B2 (ja) * 2017-09-27 2018-07-11 キテラ バイオファーマシューティカルズ，インコーポレイテッド デオキシコール酸およびその塩類の製剤
EP3700916A1 (en) 2017-10-24 2020-09-02 Bionice, S.L.U. Preparation of deoxycholic acid
CN110302082A (zh) * 2018-03-27 2019-10-08 上海同柏生物科技有限公司 用于减少身体脂肪沉积的技术及组合物制剂与应用
JP6594486B2 (ja) * 2018-06-13 2019-10-23 キテラ バイオファーマシューティカルズ，インコーポレイテッド デオキシコール酸およびその塩類の製剤
KR102116238B1 (ko) * 2018-08-28 2020-05-28 이경락 저장성 지방 분해 조성물 및 그의 제조 방법
WO2020081590A1 (en) 2018-10-16 2020-04-23 Rotunda Adam M Alcohol-based compositions and uses thereof
US11439659B2 (en) * 2018-12-03 2022-09-13 The Regents Of The University Of California Methods and compositions to prevent and treat inflammation and allergic reactions
KR102172439B1 (ko) * 2018-12-05 2020-10-30 송미희 지방 분해용 조성물 및 이를 포함하는 주사제 조성물
KR102064864B1 (ko) 2019-02-08 2020-01-10 (주)제테마 국소 주사용 조성물
KR102111346B1 (ko) 2019-08-20 2020-05-22 아영창 침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물
WO2023287261A1 (ko) 2021-07-16 2023-01-19 주식회사 스카이테라퓨틱스 담즙산 또는 담즙산 염의 분자 회합체를 포함하는 화장료 조성물
JP2024535386A (ja) * 2022-07-05 2024-09-30 グロノバ ファーマ シーオー．，エルティディー． 脂肪を減少させるための、ゲル、ゲル形成溶液、またはゲル形成懸濁液中に細胞溶解性化合物を含む注射用組成物

Family Cites Families (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113882A (en) * 1974-10-21 1978-09-12 Yamanouchi Pharmaceutical Co., Ltd. Stabilized oral prostaglandin formulation and the process for the preparation thereof
IT1202370B (it) 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
US4117121A (en) 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. Method of increasing bile flow and decreasing lipid levels
IT8167097A0 (it) 1981-01-26 1981-01-26 Unilever Nv Composizione cosmetica per il trattamento della pelle o dei capelli
US5288498A (en) 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB8417895D0 (en) 1984-07-13 1984-08-15 Marples B A Pharmaceutical anti-fungal composition
JPS61158995A (ja) * 1984-12-28 1986-07-18 Takara Shironaga 脂肪肝，胆石，胃粘膜障害発生の予防薬または治療薬
US4866044A (en) * 1985-07-09 1989-09-12 Takeda Chemical Industries, Ltd. Solubilized composition of poorly-soluble pharmaceutical product
IT1213453B (it) 1985-08-02 1989-12-20 Merz & Co Gmbh & Co Composizione farmaceutica.
US5326562A (en) 1986-06-03 1994-07-05 Incyte Pharmaceuticals, Inc. Pharmaceutical dosage unit for treating inflammation comprising protease nexin-I
US4952411A (en) 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
US5690954A (en) 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US4994439A (en) 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
IL89530A0 (en) * 1989-03-08 1989-09-10 Jeffrey J Feigenbaum Compositions containing forskolin
GB8909022D0 (en) 1989-04-20 1989-06-07 Cortecs Ltd Pharmaceutical compositions
EP0408174A1 (en) * 1989-07-12 1991-01-16 Warner-Lambert Company Antiseptic composition containing hexahydro-5-pyrimidinamine compounds
AU6461090A (en) 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5085864A (en) 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
CA2033725C (en) 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
US6120805A (en) 1990-04-06 2000-09-19 Rhone-Poulenc Rorer Sa Microspheres, process for their preparation and their use
JP3032315B2 (ja) * 1991-01-14 2000-04-17 健二 片桐 脂肪肝治療剤
GB9212511D0 (en) 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
US5674855A (en) 1992-08-12 1997-10-07 The Rogosin Institute Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
US6663885B1 (en) 1993-03-15 2003-12-16 A. Natterman & Cie Gmbh Aqueous liposome system and a method for the preparation of such a liposome system
GB9320597D0 (en) 1993-10-06 1993-11-24 Proteus Molecular Design Improvements in and realting to vaccines
US5395545A (en) 1993-10-21 1995-03-07 Akzo N.V. Cleaning solution for automated analyzers
BR9510510A (pt) 1994-12-22 1998-07-07 Astra Ab Formulação em aerossol farmacêutica uso da mesma e processos para fabricação da mesma para tratamento de um paciente carente de terapia
JP2740153B2 (ja) 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US5616342A (en) 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5759445A (en) 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
US20040101569A1 (en) 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
IL127956A0 (en) 1996-07-11 1999-11-30 Farmarc Nederland Bv Inclusion complex containing indole selective serotonin agonist
US5952392A (en) 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US7351421B2 (en) 1996-11-05 2008-04-01 Hsing-Wen Sung Drug-eluting stent having collagen drug carrier chemically treated with genipin
WO1998037869A1 (fr) 1997-02-27 1998-09-03 Nippon Shinyaku Co., Ltd. Emulsion grasse s'administrant par voie orale
US5891083A (en) 1997-04-22 1999-04-06 Capella; Rafael F. Suction lipolysis
US20020107291A1 (en) 1997-05-26 2002-08-08 Vincenzo De Tommaso Clear, injectable formulation of an anesthetic compound
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6416779B1 (en) 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
JP2002504123A (ja) 1997-06-13 2002-02-05 ユニバーシティ・オブ・ネブラスカ・ボード・オブ・リージェンツ 生物学的物質をデリバリーするための組成物およびその製法
US6638621B2 (en) 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6281175B1 (en) * 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US20050158408A1 (en) 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7303768B2 (en) 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
CN1205922C (zh) 1998-07-24 2005-06-15 柳署弘 制备含有胆汁酸的澄清水溶液剂型
TW570805B (en) * 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6417179B1 (en) 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
US6849263B2 (en) 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US6451286B1 (en) 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US6375975B1 (en) 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
ATE294571T1 (de) 1999-03-03 2005-05-15 Lilly Co Eli Echinocandin pharmazeutische zusammensetzungen
US6350432B1 (en) 1999-03-19 2002-02-26 Generex Pharmaceuticals Incorporated Pressurized container having an aerosolized pharmaceutical composition
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6489312B1 (en) * 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
US6225343B1 (en) 1999-06-16 2001-05-01 Nastech Pharmaceutical Company, Inc. Compositions and methods comprising morphine gluconate
AU3668501A (en) 2000-02-04 2001-08-14 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
GB0009773D0 (en) 2000-04-19 2000-06-07 Univ Cardiff Particulate composition
FR2813189B1 (fr) 2000-08-31 2003-02-28 Oreal Creme cosmetique moussante pour le traitement des peaux grasses
WO2002021121A1 (en) * 2000-09-08 2002-03-14 Dow Global Technolgies Inc. Sequential detection ion chromatography
EP1343492B1 (en) 2000-11-22 2006-02-01 Rxkinetix, Inc. Treatment of mucositis
AU2002216301A1 (en) 2000-12-13 2002-06-24 Janos Feher Pharmaceutical compositions for treatment of digestive disorders and associated diseases
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20030072807A1 (en) 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US20040022862A1 (en) 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US20030053956A1 (en) 2001-01-24 2003-03-20 Thomas Hofmann Alkylaryl polyether alcohol polymers for treatment and prophylaxis of snoring, sleep apnea, sudden infant death syndrome and for improvement of nasal breathing
SE0100901D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab New composition
PT1389089E (pt) 2001-03-27 2009-11-30 Phares Pharm Res Nv Processo e composição para solubilizar um composto biologicamente activo com uma baixa solubilidade em água
US20030027833A1 (en) 2001-05-07 2003-02-06 Cleary Gary W. Compositions and delivery systems for administration of a local anesthetic agent
CA2662967C (en) 2001-06-14 2012-04-10 Otsuka Pharmaceutical Co., Ltd. Medicinal composition
US20030083286A1 (en) 2001-08-22 2003-05-01 Ching-Leou Teng Bioadhesive compositions and methods for enhanced intestinal drug absorption
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US6713470B2 (en) 2002-01-22 2004-03-30 Ml Laboratories Plc Method of treatment
GB0207529D0 (en) * 2002-04-02 2002-05-08 Norbrook Lab Ltd Injectable veterinary composition for small animals
US20040018242A1 (en) 2002-05-06 2004-01-29 Elan Pharma International Ltd. Nanoparticulate nystatin formulations
MXPA04011584A (es) 2002-05-23 2005-03-31 Umd Inc Composiciones y metodo para la administracion y crioproteccion de drogas transmucosales.
BR0313060A (pt) 2002-07-29 2005-06-28 Transform Pharmaceuticals Inc Composições farmacêuticas aquosas de 2,6-diisopropilfenol
US20040220283A1 (en) 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US20050163821A1 (en) 2002-08-02 2005-07-28 Hsing-Wen Sung Drug-eluting Biodegradable Stent and Delivery Means
US20050019404A1 (en) 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
KR100482269B1 (ko) 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
EP1555976A4 (en) 2002-10-29 2007-11-14 Transform Pharmaceuticals Inc Propofol with cysteine
US20050079228A1 (en) 2003-05-30 2005-04-14 Ashish Jaiswal Clear, stable topical compositions of clarithromycin and processes for their preparation
CA2536378A1 (en) 2003-08-22 2005-03-10 Activbiotics, Inc. Rifamycin analogs and uses thereof
DE10349979B4 (de) * 2003-10-24 2006-05-18 Sanofi-Aventis Deutschland Gmbh Medikamentöse gezielte lokale Lipolyse
US20050089555A1 (en) 2003-10-24 2005-04-28 Aventis Pharma Deutschland Gmbh Medicinal targeted local lipolysis
DE10361067A1 (de) 2003-12-22 2005-07-14 Aventis Pharma Deutschland Gmbh Medikamentöse Lipolyse von Fettansammlungen
US20050143347A1 (en) 2003-12-22 2005-06-30 Aventis Pharma Deutschland Gmbh Medicinal lipolysis of accumulations of fat
WO2005063205A2 (en) 2003-12-22 2005-07-14 Aventis Pharmaceuticals Inc. Injectable phosphatidylcholine preparations
KR100638041B1 (ko) 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
PL1758590T3 (pl) * 2004-05-19 2012-03-30 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Zastosowanie detergentu do niechirurgicznego usuwania tłuszczu
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
FR2870741B1 (fr) 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
CN1960707B (zh) 2004-06-03 2012-11-14 博莱科瑞士股份有限公司 用于治疗和/或诊断用途的脂质集合体
US20050287199A1 (en) 2004-06-28 2005-12-29 Teresa Ann Denney Therapeutic micro nutrient composition for lipolysis and drug delivery
BRPI0418963A (pt) * 2004-07-20 2007-12-04 Libbs Farmaceutica Ltda composição para redução de gordura localizada, uso de compostos tensoativos farmceuticamente aceitáveis e métodos para redução de gordura localizada
US20060074057A1 (en) 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
US20060222695A1 (en) 2005-04-01 2006-10-05 Filiberto Zadini Deoxycholic acid liposome-based dermatological topical preparation

Also Published As

Publication number Publication date
DK2422789T3 (en) 2018-02-26
PT2422789T (pt) 2018-02-26
CY1120146T1 (el) 2018-12-12
IL179008A (en) 2010-12-30
US8298556B2 (en) 2012-10-30
PT2380576T (pt) 2020-06-17
DK1758590T3 (da) 2011-11-21
NZ551000A (en) 2010-10-29
AU2005245002B2 (en) 2011-07-07
ES2795749T3 (es) 2020-11-24
LT2422789T (lt) 2018-03-12
DK2380576T3 (da) 2020-06-08
EP2422789B1 (en) 2017-11-22
SI1758590T1 (sl) 2012-03-30
CY2018008I1 (el) 2020-05-29
CA2567298A1 (en) 2005-12-01
NL301229I2 (nl) 2023-11-23
KR101217497B1 (ko) 2013-01-03
KR101217497B9 (ko) 2022-01-11
SI2422789T1 (en) 2018-07-31
EP1758590A1 (en) 2007-03-07
EP2550968A1 (en) 2013-01-30
HK1101062A1 (en) 2007-10-05
EP2572718A1 (en) 2013-03-27
IL207126A (en) 2014-02-27
NZ586818A (en) 2012-09-28
MXPA06013437A (es) 2007-03-23
IL179008A0 (en) 2007-05-15
HK1099521A1 (en) 2007-08-17
DK1748780T3 (da) 2011-11-21
ES2660172T3 (es) 2018-03-21
JP2012176966A (ja) 2012-09-13
PL1758590T3 (pl) 2012-03-30
HUS1700004I1 (hu) 2017-02-28
PL3692995T3 (pl) 2023-05-22
FR20C1048I2 (fr) 2024-03-08
US20050261258A1 (en) 2005-11-24
LTPA2017006I1 (lt) 2017-03-27
EP3424508B1 (en) 2021-05-05
WO2005112942A1 (en) 2005-12-01
FR20C1048I1 (fr) 2020-11-27
SI2380576T1 (sl) 2020-10-30
EP3424508A1 (en) 2019-01-09
WO2005117900A1 (en) 2005-12-15
ATE518565T1 (de) 2011-08-15
CY2018008I2 (el) 2024-09-20
ATE521355T1 (de) 2011-09-15
EP3692995B1 (en) 2022-11-02
EP2380576A2 (en) 2011-10-26
SI1748780T1 (sl) 2012-02-29
FI3692995T3 (fi) 2023-03-02
EP2380576A3 (en) 2012-02-22
BE2017C063I2 (h) 2025-02-07
CY1111974T1 (el) 2015-11-04
IL207126A0 (en) 2010-12-30
PT1758590E (pt) 2011-11-15
HUE038247T2 (hu) 2018-10-29
PT3692995T (pt) 2023-02-06
EP2380576B1 (en) 2020-04-08
HUE049990T2 (hu) 2020-11-30
KR20070024527A (ko) 2007-03-02
HUE061343T2 (hu) 2023-06-28
CY1112204T1 (el) 2015-12-09
US20060154906A1 (en) 2006-07-13
JP2007538104A (ja) 2007-12-27
LT2380576T (lt) 2020-08-10
PL2422789T3 (pl) 2018-09-28
EP1748780A1 (en) 2007-02-07
CN101018553B (zh) 2015-11-25
EP1758590B1 (en) 2011-08-24
AU2005245002C1 (en) 2011-12-15
AU2005245002B8 (en) 2011-12-15
EP2422789A1 (en) 2012-02-29
TR201802446T4 (tr) 2018-03-21
PT1748780E (pt) 2011-11-10
US20100048527A1 (en) 2010-02-25
AU2005245002A1 (en) 2005-12-01
HUS2300016I1 (hu) 2023-05-28
CN101018553A (zh) 2007-08-15
US7622130B2 (en) 2009-11-24
CA2567298C (en) 2013-07-09
DK3692995T3 (da) 2023-01-30
ES2372416T3 (es) 2012-01-19
ES2939383T3 (es) 2023-04-21
JP5060295B2 (ja) 2012-10-31
PL1748780T3 (pl) 2012-03-30
EP3692995A1 (en) 2020-08-12
FR23C1018I1 (fr) 2023-06-23
CN105233287A (zh) 2016-01-13
EP1748780B1 (en) 2011-08-03

Similar Documents

Publication Publication Date Title
ES2372499T3 (es) Uso de un detergente para la eliminación no quirúrgica de grasa.
Rotunda et al. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution
US7754230B2 (en) Methods and related compositions for reduction of fat
US20160339042A1 (en) Topical lipolysis compositions and methods
PT1853303E (pt) Composições estabilizadas para administração tópica, e métodos para a sua preparação
CN112979762A (zh) 环肽piz及其用途
HK40002887A (en) Use of sodium deoxycholate for the non-surgical removal of fat
HK40002887B (en) Use of sodium deoxycholate for the removal of localized fat accumulation
HK1101062B (en) Use of a detergent for the non-surgical removal of fat
HK1167319B (en) Injectable composition comprising sodium deoxycholate
ES2958970T3 (es) Composiciones para uñas con propiedades antifúngicas
HK1167319A (en) Injectable composition comprising sodium deoxycholate
ES2904222T3 (es) Composiciones para la piel que comprenden turmeronas
RU2481845C2 (ru) Стабилизированная композиция местного применения, обладающая противоугревым и антибиотическим действием
ES2739453T3 (es) Métodos y composiciones relacionadas para la reducción de grasa y el estiramiento de la piel
BR112019008065B1 (pt) Composição para reduzir gordura, preparação para remover deposição de gordura localizada, kits, métodos para preparar uma composição e uso de fosfatidilcolina
HK1163508B (en) Use of sodium deoxycholate for the non-surgical removal of fat
HK1099521B (en) Methods and related compositions for reduction of fat
BR102012015283A2 (pt) Composto farmacológico para tratamento e remissão da psoríase ou lesões na pele e seu processo de obtenção
HK1163508A (en) Use of sodium deoxycholate for the non-surgical removal of fat